Markus Luster
About
Markus Luster is a scholar working on Endocrinology, Diabetes and Metabolism, Radiology, Nuclear Medicine and Imaging and Surgery.
According to data from OpenAlex, Markus Luster has authored 195 papers receiving a total of 7.4k indexed citations (citations by other indexed papers that have themselves been cited), including 141 papers in Endocrinology, Diabetes and Metabolism, 66 papers in Radiology, Nuclear Medicine and Imaging and 58 papers in Surgery. Recurrent topics in Markus Luster's work include Thyroid Cancer Diagnosis and Treatment (133 papers), Thyroid Disorders and Treatments (37 papers) and Thyroid and Parathyroid Surgery (34 papers). Markus Luster is often cited by papers focused on Thyroid Cancer Diagnosis and Treatment (133 papers), Thyroid Disorders and Treatments (37 papers) and Thyroid and Parathyroid Surgery (34 papers). Markus Luster collaborates with scholars based in Germany, Netherlands and Italy. Markus Luster's co-authors include Michael Laßmann, Christoph Reiners, Frederik A. Verburg, Heribert Hänscheid, Markus Dietlein, Uwe Mäder, Jan Tennvall, Wim J.G. Oyen, Luca Giovanella and Furio Pacini and has published in prestigious journals such as SHILAP Revista de lepidopterología, Endocrine Reviews and The Journal of Clinical Endocrinology & Metabolism.
In The Last Decade
Markus Luster
186 papers receiving 7.2k citations
Hit Papers
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Markus Luster Germany | 48 | 5.1k | 2.6k | 2.5k | 999 | 804 | 195 | 7.4k | ||
| Christoph Reiners Germany | 48 | 5.6k 1.1× | 3.1k 1.2× | 1.8k 0.7× | 980 1.0× | 479 0.6× | 215 | 7.6k | ||
| Marcel P. M. Stokkel Netherlands | 44 | 1.8k 0.4× | 1.9k 0.7× | 3.0k 1.2× | 636 0.6× | 828 1.0× | 243 | 7.6k | ||
| Milton D. Gross United States | 43 | 3.0k 0.6× | 3.7k 1.4× | 2.2k 0.9× | 644 0.6× | 1.4k 1.7× | 235 | 7.5k | ||
| Françoise Borson‐Chazot France | 46 | 3.4k 0.7× | 1.7k 0.6× | 644 0.3× | 2.0k 2.0× | 356 0.4× | 227 | 6.0k | ||
| Harry R. Maxon United States | 30 | 3.0k 0.6× | 1.7k 0.7× | 1.6k 0.6× | 411 0.4× | 533 0.7× | 67 | 4.4k | ||
| James C. Sisson United States | 46 | 2.7k 0.5× | 2.8k 1.1× | 1.5k 0.6× | 795 0.8× | 432 0.5× | 177 | 6.7k | ||
| Arthur B. Schneider United States | 40 | 2.8k 0.5× | 1.1k 0.4× | 1.5k 0.6× | 512 0.5× | 489 0.6× | 119 | 5.6k | ||
| Brahm Shapiro United States | 51 | 3.1k 0.6× | 4.2k 1.6× | 1.1k 0.4× | 1000 1.0× | 598 0.7× | 190 | 7.4k | ||
| Kathryn G. Schuff United States | 20 | 10.1k 2.0× | 5.7k 2.2× | 2.0k 0.8× | 1.1k 1.1× | 485 0.6× | 34 | 11.3k | ||
| Dana M. Hartl France | 45 | 4.2k 0.8× | 4.1k 1.6× | 997 0.4× | 721 0.7× | 1.4k 1.8× | 178 | 8.3k |
Countries citing papers authored by Markus Luster
Since
Specialization
Citations
This map shows the geographic impact of Markus Luster's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Markus Luster with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Markus Luster more than expected).
Fields of papers citing papers by Markus Luster
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Markus Luster. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Markus Luster. The network helps show where Markus Luster may publish in the future.
Co-authorship network of co-authors of Markus Luster
This figure shows the co-authorship network connecting the top 25 collaborators of Markus Luster. A scholar is included among the top collaborators of Markus Luster based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Markus Luster. Markus Luster is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Holzgreve, Adrien, D. Hellwig, Henryk Barthel, et al.. (2025). PET imaging utilization and trends in Germany: a comprehensive survey. European Journal of Nuclear Medicine and Molecular Imaging. 52(12). 4390–4398.
2.
Gelardi, Fabrizia, et al.. (2024). Match Point: Nuclear Medicine Imaging for Recurrent Thyroid Cancer in TENIS Syndrome—Systematic Review and Meta-Analysis. Journal of Clinical Medicine. 13(18). 5362–5362.
3.
Spreckelmeyer, Sarah, et al.. (2023). Besteht der Bedarf zur Gründung einer Nachwuchsorganisation „Young DGN“ innerhalb der Deutschen Gesellschaft für Nuklearmedizin (DGN)? Ergebnisse einer webbasierten Umfrage in der deutschen Nuklearmedizin 2021/2022. Nuklearmedizin - NuclearMedicine. 62(2). 55–60.
4.
Librizzi, Damiano, Markus Luster, Hendrik Heers, et al.. (2023). Adoption of Lutetium-177 PSMA radioligand therapy for metastatic castration resistant prostate cancer: a total population analysis in Germany from 2016 to 2020. European Journal of Nuclear Medicine and Molecular Imaging. 50(7). 2188–2195.
5.
Wirth, Lori J., Cosimo Durante, Duncan J. Topliss, et al.. (2022). Lenvatinib for the Treatment of Radioiodine-Refractory Differentiated Thyroid Cancer: Treatment Optimization for Maximum Clinical Benefit. The Oncologist. 27(7). 565–572.
6.
Avram, Anca M., Luca Giovanella, Bennett S. Greenspan, et al.. (2022). SNMMI Procedure Standard/EANM Practice Guideline for Nuclear Medicine Evaluation and Therapy of Differentiated Thyroid Cancer: Abbreviated Version.. PubMed. 63(6). 15N–35N.
7.
Maurer, Elisabeth, Monika Heinzel‐Gutenbrunner, Anja Rinke, et al.. (2021). Relevant prognostic factors in patients with stage IV small intestine neuroendocrine neoplasms. Journal of Neuroendocrinology. 34(1). e13076–e13076.
8.
Güleç, Seza, Sukhjeet Ahuja, Anca M. Avram, et al.. (2021). A Joint Statement from the American Thyroid Association, the European Association of Nuclear Medicine, the European Thyroid Association, the Society of Nuclear Medicine and Molecular Imaging on Current Diagnostic and Theranostic Approaches in the Management of Thyroid Cancer. Thyroid. 31(7). 1009–1019.
9.
Ovčariček, Petra Petranović, Frederik A. Verburg, Martha Hoffmann, et al.. (2020). Higher thyroid hormone levels and cancer. European Journal of Nuclear Medicine and Molecular Imaging. 48(3). 808–821.
10.
Verburg, Frederik A., et al.. (2017). Prävalenz von Schilddrüsenfunktionsstörungen bei älteren Menschen in Deutschland. Nuklearmedizin - NuclearMedicine. 56(1). 9–13.
11.
Doppler, Kathrin, Dávid Vadász, Annette Janzen, et al.. (2017). Dermal phospho-alpha-synuclein deposits confirm REM sleep behaviour disorder as prodromal Parkinson’s disease. Acta Neuropathologica. 133(4). 535–545.
12.
Dietlein, Markus, W. Eschner, Frank Grünwald, et al.. (2016). [Procedure guidelines for radioiodine therapy of differentiated thyroid cancer. Version 4].. PubMed. 55(3). 77–89.
13.
Grünwald, Frank, Matthias Schmidt, P. Schneider, et al.. (2016). Radioiodtherapie bei benignen Schilddrüsenerkrankungen (Version 5)*: DGN-Handlungsempfehlung (S1-Leitlinie). Nuklearmedizin - NuclearMedicine. 55(6). 213–220.
14.
Treglia, Giorgio, Pierpaolo Trimboli, Frederik A. Verburg, Markus Luster, & Luca Giovanella. (2015). Prevalence of normal TSH value among patients with autonomously functioning thyroid nodule. European Journal of Clinical Investigation. 45(7). 739–744.
15.
Francis, Gary L., Steven G. Waguespack, Andrew J. Bauer, et al.. (2015). Management Guidelines for Children with Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid. 25(7). 716–759.
16.
Luster, Markus, Theresia Weber, & Frederik A. Verburg. (2014). Differentiated thyroid cancer—personalized therapies to prevent overtreatment. Nature Reviews Endocrinology. 10(9). 563–574.
17.
Verburg, Frederik A., Markus Luster, Cristina Cupini, et al.. (2013). Implications of Thyroglobulin Antibody Positivity in Patients with Differentiated Thyroid Cancer: A Clinical Position Statement. Thyroid. 23(10). 1211–1225.
18.
Hänscheid, Heribert, Christoph Reiners, Guennadi Goulko, et al.. (2011). Facing the Nuclear Threat: Thyroid Blocking Revisited. The Journal of Clinical Endocrinology & Metabolism. 96(11). 3511–3516.
19.
Verburg, Frederik A., Helge Hebestreit, Udo Steigerwald, et al.. (2011). Reference Ranges for Analytes of Thyroid Function in Children. Hormone and Metabolic Research. 43(6). 422–426.
20.
Luster, Markus, Wölfram Karges, Sandra Pauls, et al.. (2009). Clinical value of 18F-fluorodihydroxyphenylalanine positron emission tomography/computed tomography (18F-DOPA PET/CT) for detecting pheochromocytoma. European Journal of Nuclear Medicine and Molecular Imaging. 37(3). 484–493.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Christoph Reiners Breakdown of academic impact, for papers by Marcel P. M. Stokkel Breakdown of academic impact, for papers by Milton D. Gross Breakdown of academic impact, for papers by Françoise Borson‐Chazot Breakdown of academic impact, for papers by Harry R. Maxon Breakdown of academic impact, for papers by James C. Sisson Breakdown of academic impact, for papers by Arthur B. Schneider Breakdown of academic impact, for papers by Brahm Shapiro Breakdown of academic impact, for papers by Kathryn G. Schuff Breakdown of academic impact, for papers by Dana M. Hartl